iSpecimen commits $2 million to IR consulting firm in three-month marketing deal
$ISPC is in focus after the company filed an 8-K on August 14, 2026, disclosing a $2 million consulting agreement with IR Agency LLC for financial media distribution. The deal, executed August 12, carries a…
Key takeaways
- iSpecimen ($ISPC) filed an 8-K on August 14, 2026, disclosing a $2 million consulting agreement with IR Agency LLC for financial media distribution.
- The deal, executed August 12, 2026, carries a non-refundable fee due by August 13 and authorizes up to ten news releases over a three-month term.
- The $2 million fee is fully earned upon receipt and cannot be refunded, even if iSpecimen exits during the initial term.
- IR Agency LLC operates as a non-exclusive independent contractor barred from soliciting orders, making investment recommendations, or effecting securities transactions.
- CEO Katharyn Field signed the Form 8-K, with the full consulting agreement attached as Exhibit 10.1.
$ISPC is in focus after the company filed an 8-K on August 14, 2026, disclosing a $2 million consulting agreement with IR Agency LLC for financial media distribution. The deal, executed August 12, carries a non-refundable fee and authorizes up to ten news releases over a three-month term. The first release under the contract is the next milestone to watch.
The arrangement
iSpecimen Inc., the Woburn, Massachusetts biospecimen marketplace listed on Nasdaq, agreed to pay IR Agency LLC an aggregate cash fee of $2 million by August 13, 2026, one day after signing. The fee is fully earned upon receipt and cannot be refunded. Over the three-month term starting August 12, the consultant will provide up to ten news releases along with company profiles and financial media distribution targeting the investment community. iSpecimen qualifies as an emerging growth company under the Securities Act of 1933.
IR Agency LLC operates as an independent contractor under the agreement, and the services are non-exclusive. Either party can terminate on written notice, but iSpecimen receives no refund if it exits during the initial term. The company may request an extension of the term for months in which no news distribution services are performed. The consultant can also suspend or terminate immediately if it concludes continued performance poses legal, regulatory, or reputational exposure, and no refund applies in that scenario.
The filing states the consultant agreed it will not solicit orders, make investment recommendations, provide investment advice, or effect securities transactions, and that it will comply in all material respects with applicable U.S. securities laws. Promotional materials are subject to paid-promotion disclosure requirements. The agreement also includes confidentiality provisions covering material non-public information. iSpecimen indemnifies the consultant, and disputes are governed by binding arbitration in New Jersey.
CEO Katharyn Field signed the Current Report on Form 8-K, dated August 14, 2026. The full consulting agreement is attached as Exhibit 10.1.
What to watch
The $2 million is committed regardless of how many of the ten allotted releases are actually deployed. The non-refundable structure leaves iSpecimen no contractual path to recover the fee, making the first news release under the agreement the next concrete event for the tape.
Related reading
- Hive Digital downgraded ahead of earnings as 10-Q delay adds to the setup
- OBOOK Holdings preliminary H1 revenue expected between $3.85 million and $3.90 million as OwlPay Harbor scales
- Revolution Medicines (RVMD) Draws M&A Scrutiny on Daraxonrasib FDA Acceptance
- FRMI in focus after $6.5 billion TensorWave lease gives Fermi its first committed Project Matador tenant